Moxaclav (1 gm+200 mg)/20 ml (IV Injection)
1.2 gm vial: ৳ 300.00
Medicine Details
Category | Details |
---|---|
Generic | Amoxicillin clavulanic acid |
Company | Square pharmaceuticals plc |
Also available as |
Indications
- Short-term treatment of bacterial infections
- Upper respiratory tract infections
- Lower respiratory tract infections
- Genito-urinary tract infections
- Skin and soft tissue infections
- Bone and joint infections
- Pharmacological action against a broad spectrum of bactericidal activity
Composition
- 375 mg tablet composition
- 625 mg tablet composition
- 1 gm tablet composition
- Powder for Suspension composition
- Powder for Suspension (Forte) composition
- 1.2 gm Injection composition
- 0.6 gm injection composition
Pharmacology
- Antibacterial combination of Amoxicillin and Clavulanic Acid
- Spectrum of bactericidal activity
- Inactivation of beta-lactamase enzymes
- Optimized absorption at the start of a meal
Dosage
- Dosage for adults and children over 12 years
- Recommended tablet dosage
- Recommended suspension dosage
- Recommended forte suspension dosage
- Recommended IV injection dosage
Administration
- Oral dosage form administration
- Enhanced absorption with start of a meal
- IV injection administration
Interaction
- Prolongation of bleeding time
- Reduction of oral contraceptives efficacy
- Concomitant use of allopurinol
- Data on concomitant use of Co-amoxiclav and allopurinol
Contraindications
- Contraindicated for Penicillin hypersensitivity
- Possible cross-sensitivity with other beta-lactam antibiotics
- History of Co-amoxiclav or Penicillin-associated cholestatic jaundice
Side effects
- Uncommon and mostly mild
- Diarrhea
- Pseudomembranous colitis
- Indigestion
- Nausea
- Vomiting
- Candidiasis
- Hepatitis
- Cholestatic jaundice
- Urticarial and erythematous rashes
- Erythema multiforme
- Stevens-Johnson Syndrome
- Exfoliative dermatitis
- Angioedema
- Anaphylaxis
Pregnancy lactation
- No teratogenic effect observed in animal studies
- Limited use in human pregnancy
- Detection of Amoxicillin in breast milk during lactation
Precautions warnings
- Caution in patients on anticoagulation therapy
- Caution in patients with severe hepatic dysfunction
- Dosage adjustment for moderate or severe renal impairment
- Maintenance of adequate fluid intake and urinary output
Special populations
- Dose adjustment for renal impairment
- Dose adjustment in hepatic impairment
Overdose effects
- Unlikely to occur
- Gastrointestinal symptoms
- Disturbance of fluid and electrolyte balances
Therapeutic class
- Broad spectrum penicillins
Reconstitution
- Reconstitution of IV injection
- Incompatible reconstitution or mixing substances
- Injection into infusion fluids
Storage conditions
- Storage condition below 25°C
- Protection from light and moisture
- Refrigeration of reconstituted suspension
- Time limit for reconstituted vial usage
Related Brands
- Co-Clav (125 mg+31.25 mg)/5 ml (Powder for Suspension) - ad-din-pharmaceuticals-ltd
- Co-Clav 500 mg+125 mg (Tablet) - ad-din-pharmaceuticals-ltd
- Mimoxclav 500 mg+125 mg (Tablet) - albion-laboratories-limited
- Fortimox 500 mg+125 mg (Tablet) - kumudini-pharma-ltd
- Fimoxyclav ES (600 mg+42.9 mg)/5 ml (Powder for Suspension) - synovia-pharma-plc